\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ patient\\ is\\ pending\\ angiography\\ for\\ definitive\\ diagnosis\\.\ \(1\)\
\-\ the\\ planar\\ image\\ demonstrates\\ decreased\\ size\\ of\\ the\\ left\\ kidney\\ with\\ decreased\\ radiotracer\\ uptake\\;\\ and\\ an\\ irregular\\ contour\\ of\\ the\\ right\\ kidney\\ with\\ increased\\ uptake\\ inferiorly\\ \ \(0\)\
\-\ which\\ correlate\\ with\\ mri\\ findings\\ of\\ hypertrophy\\ of\\ the\\ lower\\ pole\\ of\\ the\\ right\\ kidney\\.\\ \\ differential\\ function\\ is\\ 17\\.7\\%\\ on\\ the\\ left\\ and\\ 82\\.3\\%\\ on\\ the\\ right\\.\ \(0\)\
\-\ renovascular\\ hypertension\ \(2\)\
\-\ fibromuscular\\ dysplasia\ \(11\)\
\-\ arteriovenous\\ malformation\ \(22\)\
\-\ vasculitis\ \(67\)\
\-\ 6\\ year\\ old\\ female\\ with\\ hypertension\\.\\ \\ on\\ ultrasound\\ the\\ left\\ kidney\\ demonstrated\\ parvus\\ tardus\\ waveform\\ suggestive\\ of\\ renal\\ artery\\ stenosis\\.\\ \\ mri\\/mra\\ of\\ the\\ kidneys\\ demonstrated\\ bilateral\\ renal\\ scarring\\ with\\ severe\\ stenosis\\ of\\ the\\ left\\ renal\\ artery\\ and\\ hypertrophy\\ of\\ the\\ lower\\ pole\\ of\\ the\\ right\\ kidney\\.\\ \\ the\\ two\\ right\\ renal\\ arteries\\ were\\ normal\\.\ \(0\)\
\-\ fibromuscular\\ dysplasia\\ \\(fibrous\\ renal\\ artery\\ disease\\)\\ is\\ the\\ most\\ frequent\\ cause\\ of\\ renovascular\\ hypertension\\ in\\ children\\,\\ which\\ makes\\ up\\ 40\\ to\\ 80\\ percent\\ of\\ cases\\.\\ \\ four\\ types\\ of\\ fibrous\\ renal\\ artery\\ disease\\ exist\\:\\ medial\\ fibroplasia\\,\\ perimedial\\ fibroplasia\\,\\ medial\\ hyperplasia\\ and\\ intimal\\ fibroplasia\\.\\ \\ medial\\ fibroplasias\\ \\(75\\%\\ of\\ lesions\\)\\ affect\\ the\\ distal\\ half\\ of\\ the\\ main\\ renal\\ artery\\ extending\\ frequently\\ into\\ major\\ branches\\ and\\ is\\ often\\ bilateral\\.\\ \\ angiography\\ demonstrates\\ multiple\\ aneurysms\\ \\(\\&\\#8220\\;string\\ of\\ beads\\&\\#8221\\;\\ sign\\)\\.\\ \\ \ \(0\)\
\-\ this\\ patient\\ is\\ pending\\ angiography\\ for\\ definitive\\ diagnosis\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ schrier\\,\\ r\\.w\\.\\ \\ \\&\\#8220\\;renal\\ artery\\ stenosis\\,\\ renal\\ vascular\\ hypertension\\,\\ and\\ ischemic\\ nephropathy\\.\\&\\#8221\\;\\ \\ diseases\\ of\\ the\\ kidney\\ and\\ urinary\\ tract\\.\\ \\ 7th\\ ed\\.\ \(0\)\
\-\ thrall\\,\\ j\\.\\ and\\ zeissman\\,\\ h\\.\\ \\ \\&\\#8220\\;genitourinary\\ system\\.\\&\\#8221\\;\\ \\ nuclear\\ medicine\\:\\ the\\ requisites\\.\\ \\ 2nd\\ ed\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ fibroplasia\\:\\ 0\\.07742715185918116\ \(0\)\
\-\ renal\\:\\ 0\\.07728187272616262\ \(0\)\
\-\ \\#\\:\\ 0\\.06725792546369676\ \(0\)\
\-\ 8220\\:\\ 0\\.06640428608659142\ \(0\)\
\-\ 8221\\:\\ 0\\.06640428608659142\ \(0\)\
\-\ kidney\\:\\ 0\\.06040903254280956\ \(0\)\
\-\ \\&\\:\\ 0\\.06022851957474445\ \(0\)\
\-\ renovascular\\:\\ 0\\.0516181012394541\ \(0\)\
\-\ artery\\:\\ 0\\.051060802517221386\ \(0\)\
\-\ \\;\\:\\ 0\\.04741788735507744\ \(0\)\
\-\ hypertension\\:\\ 0\\.04506730504749415\ \(0\)\
\-\ angiography\\:\\ 0\\.043080901474088204\ \(0\)\
\-\ fibromuscular\\:\\ 0\\.037173390541438235\ \(0\)\
\-\ stenosis\\:\\ 0\\.03358653795482977\ \(0\)\
\-\ parvus\\:\\ 0\\.029483339210590296\ \(0\)\
\-\ tardus\\:\\ 0\\.029483339210590296\ \(0\)\
\-\ perimedial\\:\\ 0\\.029483339210590296\ \(0\)\
\-\ fibroplasias\\:\\ 0\\.029483339210590296\ \(0\)\
\-\ schrier\\:\\ 0\\.029483339210590296\ \(0\)\
\-\ r\\.w\\:\\ 0\\.029483339210590296\ \(0\)\
\-\ nephropathy\\.\\:\\ 0\\.029483339210590296\ \(0\)\
\-\ system\\.\\:\\ 0\\.029483339210590296\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.02940921616167157\ \(0\)\
\-\ definitive\\:\\ 0\\.028230090794862266\ \(0\)\
\-\ medial\\:\\ 0\\.027424409835351694\ \(0\)\
\-\ 82\\.3\\:\\ 0\\.02716512121540653\ \(0\)\
\-\ zeissman\\:\\ 0\\.02716512121540653\ \(0\)\
\-\ pole\\:\\ 0\\.02661696666899679\ \(0\)\
\-\ 17\\.7\\:\\ 0\\.024846903220222767\ \(0\)\
\-\ pending\\:\\ 0\\.024732606097322696\ \(0\)\
\-\ ed\\:\\ 0\\.024157269143074936\ \(0\)\
\-\ waveform\\:\\ 0\\.02410060371749966\ \(0\)\
\-\ fibrous\\:\\ 0\\.023105192362923563\ \(0\)\
\-\ uptake\\:\\ 0\\.022708919228723826\ \(0\)\
\-\ dysplasia\\:\\ 0\\.02256254657822545\ \(0\)\
\-\ beads\\:\\ 0\\.022528685225039004\ \(0\)\
\-\ thrall\\:\\ 0\\.022134762028863806\ \(0\)\
\-\ mri\\/mra\\:\\ 0\\.021782385722315892\ \(0\)\
\-\ intimal\\:\\ 0\\.02021046722985524\ \(0\)\
\-\ \\%\\:\\ 0\\.01999987658875593\ \(0\)\
\-\ 7th\\:\\ 0\\.019816544033680047\ \(0\)\
\-\ exist\\:\\ 0\\.019635717206689156\ \(0\)\
\-\ string\\:\\ 0\\.0193009899205454\ \(0\)\
\-\ genitourinary\\:\\ 0\\.019145404583973853\ \(0\)\
\-\ planar\\:\\ 0\\.018586695270719118\ \(0\)\
\-\ requisites\\:\\ 0\\.018460473438000564\ \(0\)\
\-\ correlate\\:\\ 0\\.017789333988294374\ \(0\)\
\-\ aneurysms\\:\\ 0\\.017145949731948367\ \(0\)\
\-\ decreased\\:\\ 0\\.016995026105181\ \(0\)\
\-\ j\\.\\:\\ 0\\.01682718658879009\ \(0\)\
\-\ demonstrated\\:\\ 0\\.016772040016434564\ \(0\)\
\-\ scarring\\:\\ 0\\.016678518486546497\ \(0\)\
\-\ affect\\:\\ 0\\.016467217812226993\ \(0\)\
\-\ makes\\:\\ 0\\.015846090234316986\ \(0\)\
\-\ branches\\:\\ 0\\.01562670132968216\ \(0\)\
\-\ percent\\:\\ 0\\.015574031239487711\ \(0\)\
\-\ half\\:\\ 0\\.015088472678134877\ \(0\)\
\-\ right\\:\\ 0\\.015077453329605629\ \(0\)\
\-\ h\\:\\ 0\\.01504357963354578\ \(0\)\
\-\ inferiorly\\:\\ 0\\.014999281216321629\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.014999281216321629\ \(0\)\
\-\ nuclear\\:\\ 0\\.014745147748168043\ \(0\)\
\-\ vasculitis\\:\\ 0\\.014624973804268165\ \(0\)\
\-\ 75\\:\\ 0\\.014624973804268165\ \(0\)\
\-\ types\\:\\ 0\\.014585856614424715\ \(0\)\
\-\ diseases\\:\\ 0\\.014396852566721232\ \(0\)\
\-\ frequent\\:\\ 0\\.014288373383600316\ \(0\)\
\-\ 2nd\\:\\ 0\\.01425298171359852\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.014081432234041492\ \(0\)\
\-\ ischemic\\:\\ 0\\.013918254427454766\ \(0\)\
\-\ bilateral\\:\\ 0\\.013871690497086581\ \(0\)\
\-\ contour\\:\\ 0\\.013855149128777899\ \(0\)\
\-\ medicine\\:\\ 0\\.013556336084176394\ \(0\)\
\-\ 80\\:\\ 0\\.01344390594772494\ \(0\)\
\-\ major\\:\\ 0\\.013361996181810908\ \(0\)\
\-\ radiotracer\\:\\ 0\\.013335132731318386\ \(0\)\
\-\ main\\:\\ 0\\.013308483334498395\ \(0\)\
\-\ urinary\\:\\ 0\\.013229786018745237\ \(0\)\
\-\ kidneys\\:\\ 0\\.013152897997926847\ \(0\)\
\-\ diagnosis\\:\\ 0\\.013125212914919197\ \(0\)\
\-\ lower\\:\\ 0\\.012855264678019148\ \(0\)\
\-\ left\\:\\ 0\\.012790705943450364\ \(0\)\
\-\ tract\\:\\ 0\\.012659132115632316\ \(0\)\
\-\ demonstrates\\:\\ 0\\.012485760546175157\ \(0\)\
\-\ four\\:\\ 0\\.012406598495203737\ \(0\)\
\-\ frequently\\:\\ 0\\.012386390085652024\ \(0\)\
\-\ children\\:\\ 0\\.01234633593499411\ \(0\)\
\-\ suggestive\\:\\ 0\\.012209807525227372\ \(0\)\
\-\ function\\:\\ 0\\.012115590545405645\ \(0\)\
\-\ 40\\:\\ 0\\.012023955180228005\ \(0\)\
\-\ references\\:\\ 0\\.011882368679135828\ \(0\)\
\-\ arteries\\:\\ 0\\.011830781821859468\ \(0\)\
\-\ irregular\\:\\ 0\\.011399152683967824\ \(0\)\
\-\ malformation\\:\\ 0\\.011399152683967824\ \(0\)\
\-\ \\:\\:\\ 0\\.011340549993217375\ \(0\)\
\-\ which\\:\\ 0\\.01066986345981638\ \(0\)\
\-\ n\\/a\\:\\ 0\\.010351861696853131\ \(0\)\
\-\ sign\\:\\ 0\\.009901158868776157\ \(0\)\
\-\ cause\\:\\ 0\\.009669774670742362\ \(0\)\
\-\ extending\\:\\ 0\\.009607756016186613\ \(0\)\
\-\ size\\:\\ 0\\.009581524653440707\ \(0\)\
\-\ cases\\:\\ 0\\.00952110656849877\ \(0\)\
\-\ is\\:\\ 0\\.009402855825831532\ \(0\)\
\-\ vascular\\:\\ 0\\.009370579491383601\ \(0\)\
\-\ disease\\:\\ 0\\.009342726028198689\ \(0\)\
\-\ often\\:\\ 0\\.009118640630500508\ \(0\)\
\-\ differential\\:\\ 0\\.009073444245327524\ \(0\)\
\-\ image\\:\\ 0\\.008927054067884953\ \(0\)\
\-\ severe\\:\\ 0\\.008793678261090315\ \(0\)\
\-\ 6\\:\\ 0\\.008535518934364128\ \(0\)\
\-\ ultrasound\\:\\ 0\\.00847867085286389\ \(0\)\
\-\ the\\:\\ 0\\.008322699413596202\ \(0\)\
\-\ two\\:\\ 0\\.008185054306408045\ \(0\)\
\-\ distal\\:\\ 0\\.00777016250483621\ \(0\)\
\-\ up\\:\\ 0\\.007685107528609443\ \(0\)\
\-\ lesions\\:\\ 0\\.007650704034595143\ \(0\)\
\-\ on\\:\\ 0\\.007263120525405633\ \(0\)\
\-\ \\(\\:\\ 0\\.007247776517496928\ \(0\)\
\-\ \\,\\:\\ 0\\.007243078676047823\ \(0\)\
\-\ \\)\\:\\ 0\\.007159241057993028\ \(0\)\
\-\ increased\\:\\ 0\\.0069915878989955035\ \(0\)\
\-\ into\\:\\ 0\\.006800422635316745\ \(0\)\
\-\ of\\:\\ 0\\.0066239619182802785\ \(0\)\
\-\ most\\:\\ 0\\.0065981108418999195\ \(0\)\
\-\ mri\\:\\ 0\\.00656613998299204\ \(0\)\
\-\ were\\:\\ 0\\.0064892519621736495\ \(0\)\
\-\ findings\\:\\ 0\\.006083066674882808\ \(0\)\
\-\ multiple\\:\\ 0\\.006019418071837019\ \(0\)\
\-\ female\\:\\ 0\\.005875452412869009\ \(0\)\
\-\ patient\\:\\ 0\\.0057297119124842\ \(0\)\
\-\ for\\:\\ 0\\.004876977582894415\ \(0\)\
\-\ and\\:\\ 0\\.004816294467751664\ \(0\)\
\-\ normal\\:\\ 0\\.004480309212706024\ \(0\)\
\-\ an\\:\\ 0\\.0039520564022900665\ \(0\)\
\-\ this\\:\\ 0\\.003214505730147602\ \(0\)\
\-\ year\\:\\ 0\\.003197676485862591\ \(0\)\
\-\ old\\:\\ 0\\.0029262026650911524\ \(0\)\
\-\ \\.\\:\\ 0\\.002137095818569341\ \(0\)\
\-\ with\\:\\ 0\\.0019565915734095275\ \(0\)\
\-\ to\\:\\ 0\\.0014283214329196864\ \(0\)\
\-\ in\\:\\ 0\\.0014093552847500165\ \(0\)\
